Kromek Share Discussion Threads

[quepassa] 08/9/2021 08:30

i have no agenda.

i have simple questions


- yet no-one seems to be able or willing to answer them.


it would, however, be only too obvious what your agenda is - just by reading your username.

[fanramptastic mate] 08/9/2021 08:12

>>>AQC

I believe Dexter was aiming the hyperbole comment at QP.

QP has an agenda and its not favourable, so to avoid even more drivel I would suggest all avoid engaging with QP and use the filter button.

happy to be holding

GLA, DYOR, NAI,& ATJ
fanny

[aqc888] 08/9/2021 08:08

Dexster, you think it’s hyperbole to say the pandemic was a national crisis?

QuePassa, what good are ventilators without ICU nurses? Can you grasp this principle? That’s why all the nightingale hospitals had zero patients. There is no global demand for ventilators - what are you basing this idea on? The ventilator fiasco was Kromek reacting to an ill conceived government request at a time of national crisis at the start of the pandemic when little was known how to react to it

[quepassa] 08/9/2021 05:20

i'd like to be.

so how many ventilators did they sell globally as per their RNS of 15/4/20 ?

simple question.

all imo. dyor.
qp

[strategicinvestor2] 08/9/2021 03:20

100% relevant to saving life’s in so many situations. We should be so proud of this company’s response.

[strategicinvestor2] 08/9/2021 03:20

100% relevant to saving life’s in so many situations. We should be so proud of this company’s response.

[quepassa] 07/9/2021 22:17

not relevant now - are you kidding - in all the third world countries crying out for any medical equipment and their hospitals crippled with covid cases due to lack of vaccine access and roll out - and you say ventilators are not relevant....??

yeah right.

all imo. dyor.
qp

[strategicinvestor2] 07/9/2021 22:12

Ventilators already covered if you read
back and not relevant now IMHO DYOR

[quepassa] 07/9/2021 21:57

All the government's fault then in the uk with the ventilators.

Ok, oh yeah right, I see......hmm.


and what about selling ventilators elsewhere in other countries and globally??

Maybe someone can ask HOW MANY VENTILATORS THEY SOLD GLOBALLY.

That's unless you already know the answer and can kindly elucidate.

For avoidance of doubt this is verbatim what Kromek said in an RNS from last year dated 15/4/20:-

"Kromek expects to commence production of ventilators before the end of April 2020 and to produce up to 2,000 units within twelve weeks, with 1,000 units available within eight weeks. Following the signing of a license agreement, which is expected shortly, Kromek intends to sell the ventilators in the UK and globally."

Simple question.

HOW MANY VENTILATORS HAVE KROMEK SOLD GLOBALLY?


ALL IMO. DYOR.
QP

[dexter1612] 07/9/2021 21:38

This has been covered loads of times, your using hyperbole, the circumstances were at the time of national crisis.....

[strategicinvestor2] 07/9/2021 21:06

I thought the AGM was to ratify the agenda items with no presentations or updates expected ? Are updates now planned ?

[aqc888] 07/9/2021 20:54

Encouraging replies to Nicks questions. I was expecting commercial roll out to be this year, as reported in IC, not this financial year, which was a little disappointing. Good to hear confirmation that there are no competitors and patents are progressing. Hopefully there will be news on the third party lab accreditation tomorrow and some firm evidence the detector works from the trials.

[aqc888] 07/9/2021 20:46

QuePassa,

Kromek agreed to build these ventilators at a time of national crisis and panic. A time when Astra Zeneca agreed to make vaccines with zero margin. A time when various other UK businesses such as Dyson were persuaded to make ventilators- only to have sold zero ventilators like Kromek.

The reason for this is that only the most severe patients in intensive care were given ventilators- less ill patients in hospital were given oxygen. There were never enough intensive care nurses to go with the ventilators. It was an error that with hindsight we can see the government made, requesting various manufacturers to make ventilators. In the end they sourced a load of faulty ones from China that went straight into storage. Kromek can be blamed for not updating the market with an RNS feed. But not for the ventilator fiasco.

[quepassa] 07/9/2021 20:35

Last year they said they were well placed for manufacturing and selling VENTILATORS under license from Metran.

Anyone recall how many ventilators Kromek said they had sold in the UK when asked that question two or three months ago?

[deedledee] 07/9/2021 20:14

Thanks Nick. A lot of promise there. AGM should be interesting.Given the responses perhaps today's sellers may yet rue their sales.

[nick2412] 07/9/2021 19:45

I heard back from Kromek with very helpful replies and will post the gist as it's not good etiquette to do a copy and paste.

Competitors?

Reply summmary:- Not aware of any with fully autonomous air sampling and diagnostic technologies with the capabilities of the Kromek-developed system.

Reply summary:- Some very early stage technologies : collect air samples but no capability to autonomously analyse the sample. Needs human intervention to produce a report and this would generally be in a laboratory.

When will the machines be commercially available?

Reply aummary:- Both within this fiscal year.

My note: I believe the Covid specific machine is due to be the first commercial launch.

Barriers to entry? Patents?

Reply summary:- Significant barriers to entry. KMK have a two year head start due to funded development that commenced in 2018. Further $13m development funds from DAPRA. Patents? Taking out patents on various aspects for both the Covid detector and the 'agnostic' bio-detecton technologies.


Expectations on KMK taking some of the UK Govt planned extra spend in the nuclear security / detection sector?

Reply summary:- Yes, well placed with portfolio of products, especially with the addition of the new D5 handheld device, to capitalise on that announced government spend.

Medical scanners £47m 7 year contract roll-out?

reply summary:- Yes progressing as planned - in line with the contract.

Benefit from UK Govt flagged up extra spend on nuclear detection / security?

Reply summary:- Yes, we believe we are well placed with our product portfolio, particularly with the addition of the new D5 handheld device, to capitalise on that announced government spend.

[dexter1612] 07/9/2021 19:09

Yeah we're all doomed.

[b00mb0y] 07/9/2021 17:24

Has the light at the end of the tunnel been extinguished? AGM tomorrow. Showcase next week. More sells than buys. Is it all over now. Nobody has any faith left in this stock

[33mick] 06/9/2021 21:01

The White House wants $65 billion for an ‘Apollo’-style pandemic preparedness program
By Lev Facher Sept. 3, 2021

"The immense funding boost would target programs aimed at developing and manufacturing vaccines, treatments, and tests more quickly. It would also provide new money for laboratory capacity, viral detection mechanisms, and early warning systems."

"It would include $3.1 billion aimed at establishing an early-warning system for new disease outbreaks, including systems to sequence pathogens found in wastewater and a “reliable clinical surveillance system.”

[nick2412] 06/9/2021 15:09

AQ, yes there are consumables which makes things interesting. Paul Hill, analyst for Equity Development, highlighted that the estimated market is £500m for bio-threat detectors and he projected that Kromek could take 20% with good profit margins. He added (Jan '21) :-

"But assuming Kromek captured 20%, this would represent a £100m pa opportunity, probably generating 25% drop through rates to boot. Which in valuation terms, using 3x sales &/or 12x EBIT multiples – might lift the market cap by £300m"


dev elopment.co.uk/hubfs/Research/Kromek/Kromek%20Group%20%20%20%2013%20%20January%202021.pdf

Just take out the space in the link as advfn's software automatically edits out links from ED.


He also highlighted there would be revenues from consumables derived from 'daily sampling' for the machines hence my question along the lines of:- how do Kromek assess the split in revenues between machine sales and consumables?

I'll be interested in the reply to your question about whether it will just be an all in one machine but I am anticipate there will be a cheaper Covid only detector that will be rolled out first then the secondary machine that will cover all bio-threats that will have both civil and military markets. Presumably the latter will be much more expensive. Whether there will be a third Covid plus other pathogens machine for civil markets I don't know.

[aqc888] 06/9/2021 13:37

I’d be interested to know what sectors have expressed the most interest in the detector ie Health, travel, education, governments..

Will Kromek release a covid detector and then later a pathogen detector that will detect all pathogens. Or will they release one that senses all pathogens.

Is the covid detector they have developed upgradable to sense other pathogens. Will the next generation detector require new hardware or just a software upgrade? (I guess this will be an important aspect governments will consider in considering how many to purchase).

How much on going revenue will the machines generate for Kromek? Are there many consumables, does it require much in the way of servicing?

[nick2412] 06/9/2021 12:45

Thanks AQ, looks like it is all in hand as holders would expect.

I have just submitted these queries to the email KMK have set up for AGM queries. It's [e-mail] in case anyone else has other questions.

1) For the Covid and other health threat virus detector, what use is it in an area of a very large number of people such as a stadium, shopping centre or airport given it doesn’t identify who has the virus and should therefore isolate immediately? In other words what helpful actions does the detector prompt when signalling virus detection for the purchaser of the product?

2) What competition does Kromek perceive exists for the bio-threat detection market?

3) Can Kromek provide an estimate of the % of the potential bio-threat detection market it is targeting?

4) Can you give updated guidance on when the Covid specific product is likely to be released for commercial sales and, likewise, for the broader bio-threat product?

5) What are the barriers to entry for potential competitors? Is Kromek strengthening its patent position?

6) Are you able to give a likely split on the revenues anticipated from machine sales and the recurring revenues from daily sampling?

7) The UK Govt has projected it will spend over £300m on nuclear threat security and detection. Do you perceive Kromek is in a good position to be a recipient of some of this spend?

8) Regarding the medical imaging scanners with the £42m 7 year contract, is rollout accelerating?

[fanramptastic mate] 06/9/2021 11:48

i like the sound of that

[aqc888] 06/9/2021 11:42

The CFO just replied to the question, that was quick...

Dear Andrew

Thank you for your email.

With regard to the biological pathogen detection system that we have developed, we have entered into a supply agreement with a global third-party contract manufacturing company to manufacture and assemble the systems. This is a scalable arrangement and is able to respond as necessary to customer demand.

Best regards

Paul